立即登录 | 免费注册
全部学科 | 内科学 | 心血管病学 | 内分泌学与糖尿病 | 神经病学 | 消化病学 | 呼吸病学 | 肿瘤学 | 妇产科学 | 骨科学
疾病中心: 高血压 | 冠心病 | 心力衰竭 | 心律失常 | 脂肪性肝病 | 糖尿病 | 卒中 | 慢性阻塞性肺病 | 子宫内膜异位症 | 乳腺癌 | 肺癌 | 结直肠癌 | 器官移植
Loading
当前位置:期刊中心 > 全球精选文摘 > 文摘导读

双侧深脑刺激与最佳医学治疗对晚期帕金森病患者疗效的比较:一项随机对照试验

Bilateral Deep Brain Stimulation vs Best Medical Therapy for Patients With Advanced Parkinson Disease: A Randomized Controlled Trial
Weaver FM, Follett K, Stern M   |    2009/5/27 10:50:00   | 
JAMA  |   2009   |    Volume 301  |   Issue 1        View at Publisher
专家评级:   |    循证评级: A   |  【全球专家评论】 |   打印| 推荐给好友
上一篇: 关于肝/脾移位和拔管预后的超声评价
下一篇: 56例Wernicke 脑病患者的MR成像所见:非酒精中毒者可能与酒精中毒者不同

Context:
Deep brain stimulation is an accepted treatment for advanced Parkinson disease (PD), although there are few randomized trials comparing treatments, and most studies exclude older patients.

Objective:
To compare 6-month outcomes for patients with PD who received deep brain stimulation or best medical therapy.

Design, Setting, and Patients:
Randomized controlled trial of patients who received either deep brain stimulation or best medical therapy, stratified by study site and patient age (<70 years vs ≥70 years) at 7 Veterans Affairs and 6 university hospitals between May 2002 and October 2005. A total of 255 patients with PD (Hoehn and Yahr stage ≥2 while not taking medications) were enrolled; 25% were aged 70 years or older. The final 6-month follow-up visit occurred in May 2006.

Intervention:
Bilateral deep brain stimulation of the subthalamic nucleus (n=60) or globus pallidus (n=61). Patients receiving best medical therapy (n=134) were actively managed by movement disorder neurologists.

Main Outcome Measures:
The primary outcome was time spent in the “on” state (good motor control with unimpeded motor function) without troubling dyskinesia, using motor diaries. Other outcomes included motor function, quality of life, neurocognitive function, and adverse events.

Results:
Patients who received deep brain stimulation gained a mean of 4.6h/d of on time without troubling dyskinesia compared with 0h/d for patients who received best medical therapy (between group mean difference, 4.5h/d [95% CI, 3.7-5.4h/d]; P<.001). Motor function improved significantly (P<.001) with deep brain stimulation vs best medical therapy, such that 71% of deep brain stimulation patients and 32% of best medical therapy patients experienced clinically meaningful motor function improvements (≥5 points). Compared with the best medical therapy group, the deep brain stimulation group experienced significant improvements in the summary measure of quality of life and on 7 of 8 PD quality-of-life scores (P<.001). Neurocognitive testing revealed small decrements in some areas of information processing for patients receiving deep brain stimulation vs best medical therapy. At least 1 serious adverse event occurred in 49 deep brain stimulation patients and 15 best medical therapy patients (P<.001), including 39 adverse events related to the surgical procedure and 1 death secondary to cerebral hemorrhage.

Conclusion:
In this randomized controlled trial of patients with advanced PD, deep brain stimulation was more effective than best medical therapy in improving on time without troubling dyskinesias, motor function, and quality of life at 6 months, but was associated with an increased risk of serious adverse events.

Trial Registration:
clinicaltrials.gov Identifier: NCT00056563.
 

关键词:

请登录后发表评论,点击此处登录。
相关文章

关注糖尿病,聚焦GLP-1!案例征集大赛

时间:2011-3~~2011-11
由中国医师协会主办、礼来国际贸易(上海)有限公司协办、爱思唯尔国际出版集团承办的“精彩案例我分享——关注糖尿病•聚焦GLP-1”案例征集活动将于2011年3月~ 11月在全国范围隆重展开。

关注青光眼患者, 让世界更明亮!

时间:2011-4~~2011-12
《中华眼科杂志》发起,辉瑞制药资助,旨在交流青光眼治疗理念,分享国内抗青光眼药物固定联合治疗经验的病例交流活动.

聚焦哮喘和COPD联合制剂治疗

时间:2010-12~~2011-12
哮喘和慢性阻塞性肺疾病(COPD)是常见、多发的气道炎症性疾病,这类疾病严重影响患者的生活质量。我们特别组织了该类案例征集活动,奖品丰厚,快来参与!

中国选择 达标看我

时间:2011-9~~2012-9
本次活动对典型病例以分享的形式总结临床经验,通过跨专科、多层次的学术交流,对降压治疗方案、疗效进行解析与点评。

 

慢性心衰诊治:规范中求突破
黄峻
2012-2-1
南京医科大学第一附属医院
房颤治疗:手段渐趋丰富 新型治疗药物不断涌现 非药物治疗备受关注
马长生
2012-2-1
首都医科大学附属北京安贞医院
注重老年人群特征 优化管理

刘梅林
2012-2-1
北京大学第一医院老年内科